Answers are grounded in this paper and cite their sources.
Prospective cohort study shows increased mortality risk in older adults with sarcopenia, suggesting a need for assessment in IBD patients.
Background: With gradually increasing number of older inflammatory bowel disease (IBD) patients, a significant number of IBD patients suffer from sarcopenia. Emerging evidence has demonstrated various adverse outcomes associated with sarcopenia, however, the impact of sarcopenia on long-term mortality risk among IBD patients has not yet been explored. Method: Overall, 4,966 IBD patients (aged 56.9±8.0 years, 51.6% female) were enrolled in the prospective cohort. Sarcopenia was assessed according to criteria of the European Working Group on Sarcopenia in Older People 2 (EWGSOP2). The primary outcome was all-cause mortality. Multivariable Cox proportional hazard model was conducted to estimate related associations. Sensitivity analysis and subgroup analysis were used to validate the results. Results: Overall, 775 (14.6 %) and 34 (0.7 %) were considered probable sarcopenia and confirmed sarcopenia, respectively. During a median follow-up of 14.6 years, 564 all-cause deaths (11.4 %) were identified. There were 136 deaths (17.5 %) among those with probable sarcopenia, and 10 deaths (29.4%) among those with confirmed sarcopenia. Compared with non-sarcopenia those with probable sarcopenia and confirmed sarcopenia had a 47% (hazard ratios [HR]=1.47, 95% confidence interval [CI]: 1.20-1.80, P<0.001) and 140% (HR=2.40, 95% CI: 1.27-4.52, P= 0.007) excess risk of mortality, respectively. Similar results were observed in sensitivity analysis. Conclusions: Probable and confirmed sarcopenia increase the risk of long-term mortality in IBD patients. Sarcopenia assessment can help risk stratification for prognosis in older IBD patients.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: